On ECHEMI
Home > Drugs > Endometritis
Endometritis
Endometritis is an inflammation of the endometrium. According to the length of the disease, it can be divided into acute endometritis and chronic endometritis. After endometritis occurs, the entire uterine cavity often becomes edematous and exudates. The acute phase can also cause systemic symptoms, such as fever, chills, increased white blood cell count, lower abdominal pain, increased leucorrhea, sometimes bloody or foul-smelling, and sometimes a slightly enlarged uterus and tenderness. The symptoms of chronic patients are basically the same, and there may also be menorrhagia, lower abdominal pain, and obvious swelling in the lumbosacral area.
  • Site of disease:

    Uterus
  • Infectious :

    Not contagious
  • Frequent population:

    Women aged 35 and above
  • Related symptoms:

    Increased leucorrhea menstrual disorders lower abdominal distension lumbar pain pelvic heaviness
  • Concurrent disease:

Related Drugs
Cefmenoxime Hydrochloride for Injection
Indication: This product is suitable for the following infections caused by ceftriaxone-sensitive Streptococci (except enterococci), Streptococcus pneumoniae, Peptococcus, Peptostreptococcus, Escherichia coli, Citrobacter, Klebsiella, Enterobacter, Serratia, Proteus, Haemophilus influenzae, Bacteroides, etc.: 1. Pneumonia, bronchitis, bronchiectasis infection, secondary infection of chronic respiratory diseases; lung abscess, empyema; 2. Pyelonephritis, cystitis; Bartholinitis, endometritis, adnexitis, pelvic inflammatory disease, parametrial tissue inflammation; 3. Cholangitis, cholecystitis, liver abscess, peritonitis; 4. Secondary infection of burns and surgical trauma; 5. Sepsis; 6. Meningitis.
Manufacturer:

Jilin Huinan Changlong BLO-CHEMICAL Pharmaceutcal Co., Ltd.

Cefmenoxime Hydrochloride for Injection
Indication: This product is suitable for the following infections caused by ceftriaxone-sensitive Streptococci (except enterococci), Streptococcus pneumoniae, Peptococcus, Peptostreptococcus, Escherichia coli, Citrobacter, Klebsiella, Enterobacter, Serratia, Proteus, Haemophilus influenzae, Bacteroides, etc.: 1. Pneumonia, bronchitis, bronchiectasis infection, secondary infection of chronic respiratory diseases; lung abscess, empyema; 2. Pyelonephritis, cystitis; Bartholinitis, endometritis, adnexitis, pelvic inflammatory disease, parametrial tissue inflammation; 3. Cholangitis, cholecystitis, liver abscess, peritonitis; 4. Secondary infection of burns and surgical trauma; 5. Sepsis; 6. Meningitis.
Manufacturer:

Jilin Huinan Changlong BLO-CHEMICAL Pharmaceutcal Co., Ltd.

Cefmenoxime Hydrochloride for Injection
Indication: This product is suitable for the following infections caused by ceftriaxone-sensitive Streptococci (except enterococci), Streptococcus pneumoniae, Peptococcus, Peptostreptococcus, Escherichia coli, Citrobacter, Klebsiella, Enterobacter, Serratia, Proteus, Haemophilus influenzae, Bacteroides, etc.: 1. Pneumonia, bronchitis, bronchiectasis infection, secondary infection of chronic respiratory diseases; lung abscess, empyema; 2. Pyelonephritis, cystitis; Bartholinitis, endometritis, adnexitis, pelvic inflammatory disease, parametrial tissue inflammation; 3. Cholangitis, cholecystitis, liver abscess, peritonitis; 4. Secondary infection of burns and surgical trauma; 5. Sepsis; 6. Meningitis.
Clindamycin Hydrochloride and Sodium Chloride Injection
Indication: 1. For the treatment of the following infectious diseases caused by Gram-positive bacteria: (1) tonsillitis, suppurative otitis media, sinusitis, etc.; (2) acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis combined infection, etc.; (3) skin and soft tissue infections: furuncle, carbuncle, abscess, fossa inflammation, trauma and postoperative infection, etc.; (4) urinary tract infections: acute urethritis, acute pyelonephritis, prostatitis, etc.; (5) others: osteomyelitis, sepsis, peritonitis and oral infection, etc.; 2. For the treatment of various infectious diseases caused by anaerobic bacteria: (1) empyema, lung abscess, anaerobic lung disease; (2) skin and soft tissue infections, sepsis; (3) intra-abdominal infections: peritonitis, intra-abdominal abscess; (4) female pelvic and genital infections: endometritis, non-gonococcal fallopian tube and ovarian abscess, pelvic fossa inflammation and post-gynecological surgery infection, etc.
Clindamycin Hydrochloride and Sodium Chloride Injection
Indication: 1. For the treatment of the following infectious diseases caused by Gram-positive bacteria: (1) tonsillitis, suppurative otitis media, sinusitis, etc.; (2) acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis combined infection, etc.; (3) skin and soft tissue infections: furuncle, carbuncle, abscess, fossa inflammation, trauma and postoperative infection, etc.; (4) urinary tract infections: acute urethritis, acute pyelonephritis, prostatitis, etc.; (5) others: osteomyelitis, sepsis, peritonitis and oral infection, etc.; 2. For the treatment of various infectious diseases caused by anaerobic bacteria: (1) empyema, lung abscess, anaerobic lung disease; (2) skin and soft tissue infections, sepsis; (3) intra-abdominal infections: peritonitis, intra-abdominal abscess; (4) female pelvic and genital infections: endometritis, non-gonococcal fallopian tube and ovarian abscess, pelvic fossa inflammation and post-gynecological surgery infection, etc.
Clindamycin Hydrochloride and Sodium Chloride Injection
Indication: 1. The product is suitable for the following infectious diseases caused by Gram-positive bacteria: 1) tonsillitis, suppurative otitis media, sinusitis, etc. 2) acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis combined infection, etc. 3) skin and soft tissue infection; furuncle, carbuncle, abscess, fossa tissue inflammation, trauma and postoperative infection, etc. 4) urinary system infection: acute urethritis, acute pyelonephritis, prostatitis, etc. 5) others: osteomyelitis, sepsis, peritonitis and oral infection, etc. 2. The product is suitable for various infectious diseases caused by anaerobic bacteria: 1) empyema, lung abscess, anaerobic lung disease. 2) skin and soft tissue infection, sepsis. 3) intra-abdominal infection: peritonitis, intra-abdominal abscess. 4) female pelvic and genital infection: endometritis, non-gonococcal fallopian tube and ovarian abscess, pelvic fossa tissue inflammation and post-gynecological surgery infection, etc.
Manufacturer:

Guangdong Litai Pharmaceutical Holdings Co., Ltd.

Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam. 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treat systemic and/or local bacterial infections caused by sensitive bacteria.
Manufacturer:

North China Pharmaceutical Company.Ltd

Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam. 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treat systemic and/or local bacterial infections caused by sensitive bacteria.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam. 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treat systemic and/or local bacterial infections caused by sensitive bacteria.
Manufacturer:

Xiangbei Welman Pharmaceutical Co., Ltd.

Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam. 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treat systemic and/or local bacterial infections caused by sensitive bacteria.
Manufacturer:

Xiangbei Welman Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.